Arcturus Therapeutics Holdings Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

ARCT
Arcturus Therapeutics Holdings

Last Price:

$12.81

Seasonality Move:

17.7%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Arcturus Therapeutics Holdings Stock Forecast

Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 47.1% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Is Arcturus Therapeutics Holdings Stock Undervalued?

The current Arcturus Therapeutics Holdings [ARCT] share price is $12.15. The Score for ARCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Arcturus Therapeutics Holdings Stock Go Up Next Year?

Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 47.1% based on the past 11 years of stock performance.

Arcturus Therapeutics Holdings Stock Rating

Sell

Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings overpriced?

Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Arcturus Therapeutics Holdings Stock Price History

Is ARCT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

arcturusrx.com

52-Week Data

52-Week High:

45.00

52-Week Low:

8.04

Prediction Charts

Market Cap:

329.5M

Price in USD:

12.15

Volume:

429.3K

Beta:

2.55

Technical Analysis

SMA50:

11.69

SMA100:

14.25

SMA200:

16.96

52-Wk Change:

-59.3%

Stock Predictions

Is Arcturus Therapeutics Holdings stock public?

Yes, Arcturus Therapeutics Holdings is a publicly traded company.
What is the Arcturus Therapeutics Holdings stock quote today?

The Arcturus Therapeutics Holdings stock price is 12.15 USD today.
How to buy Arcturus Therapeutics Holdings stock online?

You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-2	12.52	12.83	13.10	12.52
May-5	12.63	11.92	12.78	11.89
May-6	11.74	11.24	11.86	11.13
May-7	11.24	10.95	11.72	10.81
May-8	10.97	11.38	11.59	10.70
May-9	11.40	10.98	11.74	10.96
May-12	11.53	11.59	12.22	11.38
May-13	12.79	11.86	13.95	11.72
May-14	11.66	10.84	11.86	10.65
May-15	10.81	11.64	11.64	10.59
May-16	11.68	11.65	11.88	11.42
May-19	11.49	11.99	12.33	11.49
May-20	11.96	12.70	12.86	11.72
May-21	12.35	12.15	12.41	11.67

Arcturus Therapeutics Holdings Earnings

Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arcturus Therapeutics Holdings Forecast Revenue Growth

Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.54 per share, a decrease this year of $0.99 per share, and an increase next year of $0.86 per share.

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.